Clinical Trial Update: Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update noting the completion of a study evaluating tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemorrhagic Telangiectasia

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University Hospital, Saarland | Conditions: Hereditary Hemorrhagic Telangiectasia | Phase 3 | Status: COMPLETED